Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/c in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up

Infection & Chemotherapy(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要